Kawamoto found that the primary gallbladder cancer specimens had high expression of myosin-related kinase B (TrkB), and the overall survival rate of patients with high expression of TrkB in the tumor invasion front was lower than that of patients with low expression of TrkB. The gene discussed is NTRK2; the disease is neoplasm.